This article was produced by Being Patient in partnership with Charter Research. More information on Alzheimer’s clinical trials can be found on the Charter…
As the number of people with Alzheimer’s grows in the coming decades, more attention is being paid to people who develop dementia as a…
Researchers in Florida have pinpointed a protein that contributes to tau accumulation in the brain. They argue it may be a key target in…
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…
In a new study published in JAMA Neurology, researchers reported the first results of an initial basket trial for neurodegenerative diseases. The trial brings…
